Friday, November 20, 2026Published by SAM & FDPS · Our work → · Submit an op-ed →

Dr. Daniel Amen: NBA Star Julius Randle Quit Marijuana After Seeing His Brain Scan

Dr. Daniel Amen: NBA Star Julius Randle Quit Marijuana After Seeing His Brain Scan

High Stakes with Dr. Kevin Sabet NBA star Julius Randle made a dramatic decision after seeing what marijuana use looked…

By TDR StaffAugust 13, 20262 min read
Dr. Daniel Amen video still on NBA star Julius Randle quitting marijuana after seeing his brain scan

High Stakes with Dr. Kevin Sabet

NBA star Julius Randle made a dramatic decision after seeing what marijuana use looked like on his own brain scan: he stopped using it.

That’s according to renowned psychiatrist and brain-imaging expert Dr. Daniel Amen, who discussed treating Randle during his recent appearance on High Stakes with Dr. Kevin Sabet.

Amen said Randle had been using marijuana heavily and that Randle’s wife had noticed significant changes.

WANT THE TRUTH ABOUT DRUGS?

Subscribe to The Drug Report to get the latest on science, policy, and much, much more.

“His wife said it just changed his personality. And he went from happy and connected, loving, to angry and distant and dark.”

Amen said Randle was also struggling with negative thoughts and had been using marijuana as a way of coping. But seeing his brain scan proved to be a turning point.

Free weekly briefing

Get stories like this every Friday

The week's drug policy news in one email, every claim sourced. Join tens of thousands of readers.

“He saw his scan and immediately stopped.”

Amen said the experience illustrates one of the reasons he believes brain imaging can be so powerful: “If you don’t look, you don’t know.”

📺 Watch Dr. Amen tell the story of Julius Randle below.

For the full conversation—including Dr. Amen’s discussions with Kevin Sabet about marijuana, ADHD, mental health, and what he has learned from decades of studying brain scans—watch the complete episode of High Stakes.

📺 Watch the full interview:

Get The Drug Report every Friday

One free email every Friday: the week's drug policy news, sourced and explained. Read by tens of thousands of people who write, enforce and cover the policy. Unsubscribe anytime.

Scroll to Top